Emerging market debt markets have benefited from diversification inflows, though this has not meant an even lift to all boats. Bond price action has diverged between high-yielding India and Indonesia debt, with 10Y INR rate rising past 6.6% this week to a five-month high (up ~25bp this month), while Indonesia 10Y yield was at year’s low, below 6.4%. For India, markets had priced out rate cuts after the RBI’s hawkish hold earlier this month. Subsequent conciliatory remarks from the central bank that they will act if required, did not provide much relief. Markets are also wary of the impact of tariffs, softer revenue run-rate, fiscal cost from upcoming GST tax relief, and potential need for further support to businesses (to mitigate tariff related fallout). Fitch affirmed the sovereign’s ratings, not joining its peer S&P in its rating upgrade (S&P upgrades India’s sovereign credit rating). Concurrently, regulatory changes have impinged on demand by local buyers, as investors await a recalibration in duration mix in 2H bond issuance calendar to spur incremental demand. Additionally, the auction size of SDLs (state bonds) exceeded the indicative calendar and was heavy on duration, resulting in a hardening of yields.
Domestic institutional demand for debt is guarded, but foreign investors have ploughed $4.2bn yet far in CY2025 into INR debt. As yields rise, there are calls for the authorities to act, included potential open market operations. Tariff developments are in focus as the additional 25% penalty is due to go into effect today. While exemptions on pharma and semiconductors/ electronics safeguard a fourth of the export basket for now, sectors like gems & jewellery, and textiles remain vulnerable, especially smaller businesses with thin margins. We expect the impact on growth to be in the range of 25-60bp, depending on coverage of the products.
Indonesia 10Y bonds reflect a positive momentum, with yields slipping below 6.4% and front end of curve benefiting more, on the back of expectations of a dovish BI, dollar inflows, rechannelling of demand from slowing supply of SRBIs and a softening US dollar. With markets pricing in a rate cut by the US Fed in September, high yielding papers akin to IDR bonds stand to benefit from rotational flows, imparting a bull steepening impulse on the curve. Foreign interests into IDR debt have been strong at $5.2bn so far in 2025, rotating out of equities. Rates, however, look stretched at current levels with the fiscal run-rate still pointing to a weak revenue trend growth. USDIDR traded within 16200-16400, with attempts to test above running into stiff intervention presence. The country’s wealth fund Danantara plans to issue IDR 50trn ($3.1bn) worth 5Y and 10Y patriot bonds at below market yields of around 2% (less than half of the prevailing 2Y IDR yield). Launch might be planned for early-October, with markets likely to closely track investor appetite for these low-yielding papers.
GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates & Digital Asset)
The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.
[#for Distribution in Singapore] This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.
DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.
DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability. 11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply. The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.